Total Funding
52
27
Total FundingDebt Financing raised
Growth Score 52 in past quarter
-2 pts
Heat Score 27 in past quarter
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
152805
Hepavue created the first proprietary virtual liver biopsy in history, which will lower the cost, convenience, safety, and accessibility.
- Ludovic Wouters: Co-Founder, Board member and Strategic advisor
- Gaby El Alam: Co-Founder & Lead Engineer
About the Company
Hepavue has created the first proprietary virtual liver biopsy in history, which will lower the cost, convenience, safety, and accessibility of diagnosing liver illness. The Hepavue technique will stop preventable liver cancer instances, transplants, and fatalities.